PriceTargets.com logo

CareRx - CHHHF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.83
  • Forecasted Upside: 192.93%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.65 As of 03/24/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for CHHHF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CareRx Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHHHF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHHHF

Analyst Price Target is $4.83
▲ +192.93% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for CareRx in the last 3 months. The average price target is $4.83, with a high forecast of $5.25 and a low forecast of $4.25. The average price target represents a 192.93% upside from the last price of $1.65.

This chart shows the closing price for CHHHF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in CareRx. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/10/2023DesjardinsLower TargetC$4.50 ➝ C$4.25
3/10/2023Stifel NicolausLower TargetC$6.20 ➝ C$5.00
3/2/2023DesjardinsLower TargetC$5.00 ➝ C$4.50
11/11/2022DesjardinsLower TargetC$5.50 ➝ C$5.00
11/10/2022Canaccord Genuity GroupLower TargetBuy ➝ BuyC$6.50 ➝ C$5.25
11/10/2022Stifel NicolausLower TargetC$6.50 ➝ C$6.20
8/17/2022DesjardinsLower TargetC$7.00 ➝ C$6.00
8/16/2022Stifel NicolausLower TargetC$7.50 ➝ C$6.50
5/16/2022DesjardinsLower TargetC$10.00 ➝ C$8.50
5/15/2022Canaccord Genuity GroupLower TargetBuy ➝ BuyC$8.50 ➝ C$8.00
3/22/2022DesjardinsBoost TargetC$9.50 ➝ C$10.00
5/21/2021DesjardinsBoost TargetBuyC$7.50 ➝ C$10.00
2/4/2021DesjardinsInitiated CoverageBuy
6/29/2020Stifel NicolausInitiated CoverageBuy
(Data available from 3/26/2018 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
CareRx logo
CareRx Corp. engages in the provision of pharmacy and other healthcare services. It offers services for patients, solutions for insurers, solutions for employers, and solutions for long term care homes and retirement residences. The company was founded by Brenda Rasmussen on February 2, 2001 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $1.65
Low: $1.65
High: $1.65

50 Day Range

MA: $1.93
Low: $1.65
High: $2.00

52 Week Range

Now: $1.65
Low: $1.62
High: $4.37

Volume

N/A

Average Volume

840 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of CareRx?

The following Wall Street sell-side analysts have issued stock ratings on CareRx in the last twelve months: Canaccord Genuity Group Inc., Desjardins, and Stifel Nicolaus.
View the latest analyst ratings for CHHHF.

What is the current price target for CareRx?

3 Wall Street analysts have set twelve-month price targets for CareRx in the last year. Their average twelve-month price target is $4.83, suggesting a possible upside of 192.9%. Canaccord Genuity Group Inc. has the highest price target set, predicting CHHHF will reach $5.25 in the next twelve months. Desjardins has the lowest price target set, forecasting a price of $4.25 for CareRx in the next year.
View the latest price targets for CHHHF.

What is the current consensus analyst rating for CareRx?

CareRx currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CHHHF will outperform the market and that investors should add to their positions of CareRx.
View the latest ratings for CHHHF.

What other companies compete with CareRx?

Other companies that are similar to CareRx include Bumrungrad Hospital Public, Field Trip Health, Greenbrook TMS, Greenbrook TMS and Invesque. Learn More about companies similar to CareRx.

How do I contact CareRx's investor relations team?

CareRx's physical mailing address is 20 Eglinton Avenue West, Toronto, ON M4R. The company's listed phone number is (647) 361-4499. The official website for CareRx is www.carerx.ca. Learn More about contacing CareRx investor relations.